Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Details : TS-1 is a combination of three pharmacological compounds: tegafur, an antimetabolite agent that, after absorption by the gastrointestinal tract, is converted into the anticancer agent fluorouracil (5-FU); gimeracil (5-chloro-2, 4-dihydroxypyridine, or CD...
Brand Name : TS-1
Molecule Type : Small molecule
Upfront Cash : Not Applicable
November 24, 2022
Positive EMA Opinion for the Use of Teysuno in Metastatic Colorectal Cancer
Details : Based on the positive opinion from EMA, Teysuno (Tegafur) an oral fluoropyrimidine will be indicated in adults for the treatment of advanced gastric cancer when given in combination with cisplatin.
Brand Name : Teysuno
Molecule Type : Small molecule
Upfront Cash : Not Applicable
January 04, 2022
LOOKING FOR A SUPPLIER?